This workshop is special as this is ILCA’s inaugural Single Topic Workshop (STW). We have chosen the topic of prevention, risk stratification, and early detection as these areas arguably have the greatest potential to reduce HCC-related mortality. We will discuss recent advances in each of these areas as well as areas in need of continued research.

Single Topic Workshop is about:

The past few years have seen significant changes in the management of liver cancer and the Single Topic Workshop initiative was established in recognition of the rapidly changing therapeutic landscape. Each STW will focus on a specific area in which recent developments have transformed the field of HCC. ILCA aims to provide delegates with state-of-the-art lectures delivered by leading experts and anticipate that these meetings will be of interest to all disciplines engaged in delivering care to patients with liver cancer.

Who should Attend?

Clinical and translational researchers, clinicians (primarily GI/hepatology), and industry representatives interested in HCC prevention, early detection or biomarkers. Talks may have Western focus (cirrhosis instead of HBV) although can interest delegates from Asia.

What to Expect

• Understand at-risk patients and current recommendations for HCC surveillance
• Identify barriers to HCC surveillance and potential strategies to improve surveillance effectiveness
• Describe proven as well as promising chemoprevention strategies for HCC in patients with cirrhosis


11 June 2020




13:00 – 13:15 Welcome & Introduction by the STW Co-chairs Tim Meyer & Amit Singal
13:15 – 13:40 Risk stratification biomarkers – are we close? Yujin Hoshida
13:40 – 14:05 Risk stratification after resection: Can we tailor surveillance for recurrence Eric Vibert
14:05 – 14:30 HCC chemoprevention: Current options and the horizon Tracey Simon
14:30- 15:00 Panel Discussion All
15:00 – 15:20 Coffee Break
15:20 – 15:45 Biomarkers for HCC diagnosis Josep M. Llovet
15:45 – 16:10 Biomarkers for HCC prognosis and treatment response Tim Meyer
16:10- 16:40 Panel Discussion All


12 June 2020




08:30 – 08:50 HCC surveillance – current recommendations and supporting evidence Maria Reig
08:50 – 09:10 HCC surveillance utilization and potential interventions Amit Singal
09:10 – 09:30 Limitations of HCC surveillance test effectiveness and alternative imaging Valerie Vilgrain
09:30 – 09:50 Precision screening for HCC: Is it possible and what do we need? Pierre Nahon
09:50 – 10:20 Panel Discussion All
10:20 – 10:40 Coffee Break
10:40 – 11:00 Phases of biomarker validation Jorge Marrero
11:00 – 11:20 Emerging serum biomarkers for early HCC detection Philip Johnson
11:20 – 11:40 cfDNA for early HCC detection Beatriz Minguez
11:40 – 12:10 Panel Discussion All
12:10 – 13:30 Lunch
13:30 – 13:50 Patient advocacy perspective Andrea Wilson
13:50 – 14:05 Bench to bedside: commercialization of biomarkers Jeff Winick
14:05 – 14:20 Bench to bedside: commercialization of biomarkers Marilyn Olson
14:20 – 14:30 Closing by the STW Co-chairs Tim Meyer & Amit Singal

Single Topic Workshop venue in Paris will be announced in the following days on this website.

We will publish further details on venue/hotel along with information on how to book your accommodation.

ILCA is happy to invite you to join us for the first edition of the SINGLE TOPIC WORKSHOP (STW).

STW 2020 is taking place in the beautiful city of Paris on 11th – 12th June 2020.

Registrations now are open with the early bird deadline on 20th April 2020.

Register Here

The programme has been developed by the STW chairs and we are excited to share this with you in June. We have lined up a wide range of very prominent speakers.

The workshop will run from Thursday, 11th June until Friday, 12th June.

ILCA Single Topic Workshop Registration fees

Member Registration Early Registration before 20th April 2020


Member Registration Regular


Non-Member Registration Early Registration before 20th April 2020


Non-Member Registration Regular


To download the STW pdf template please click here.

Meet the Chairs

Dr. Amit Singal
STW Co-Chair
UT Southwestern Medical Center, USA

Dr. Tim Meyer
STW Co-Chair
UCL Cancer Institute, University College, UK